drugset / Trial / NCT04809116
Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept
NaSingle-groupOpen-labelTreatment
Summary
This is a proof-of-concept, open-label trial of pimavanserin 34mg at bedtime for 6 weeks in Veterans with insomnia and Posttraumatic Stress Disorder.
Timeline
- Start
- 2022-12-15
- Primary completion
- 2023-12-15
- Completion
- 2023-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pimavanserin | Small molecule | 34 mg | — |